|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
100 Clinical Results associated with CSF-2R x CTLA4 x CD28
100 Translational Medicine associated with CSF-2R x CTLA4 x CD28
0 Patents (Medical) associated with CSF-2R x CTLA4 x CD28